JPWO2022202985A1 - - Google Patents
Info
- Publication number
- JPWO2022202985A1 JPWO2022202985A1 JP2023509295A JP2023509295A JPWO2022202985A1 JP WO2022202985 A1 JPWO2022202985 A1 JP WO2022202985A1 JP 2023509295 A JP2023509295 A JP 2023509295A JP 2023509295 A JP2023509295 A JP 2023509295A JP WO2022202985 A1 JPWO2022202985 A1 JP WO2022202985A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021050468 | 2021-03-24 | ||
| PCT/JP2022/013912 WO2022202985A1 (ja) | 2021-03-24 | 2022-03-24 | ペプチド、及び該ペプチドを有効成分として含有する組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2022202985A1 true JPWO2022202985A1 (https=) | 2022-09-29 |
Family
ID=83397360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023509295A Pending JPWO2022202985A1 (https=) | 2021-03-24 | 2022-03-24 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240158440A1 (https=) |
| EP (1) | EP4317173A4 (https=) |
| JP (1) | JPWO2022202985A1 (https=) |
| CN (1) | CN116997561A (https=) |
| WO (1) | WO2022202985A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118785917A (zh) * | 2021-12-15 | 2024-10-15 | 维格治疗股份有限公司 | 治疗性肽的用途 |
| WO2024259556A1 (en) * | 2023-06-19 | 2024-12-26 | Viage Therapeutics, Inc. | Uses of therapeutic peptides |
| WO2025173704A1 (ja) * | 2024-02-16 | 2025-08-21 | エフバイタル株式会社 | 薬剤のスクリーニング方法、および剤 |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001136995A (ja) * | 1999-11-11 | 2001-05-22 | Calpis Co Ltd | トリペプチドの製造方法 |
| JP2012031139A (ja) * | 2009-12-28 | 2012-02-16 | Calpis Co Ltd | 脳機能改善作用を有するペプチド |
| US20120077751A1 (en) * | 2003-10-08 | 2012-03-29 | Yu Tian Wang | Methods for modulating neuronal responses |
| JP2015519878A (ja) * | 2012-03-26 | 2015-07-16 | プロニュートリア・インコーポレイテッドＰｒｏｎｕｔｒｉａ， Ｉｎｃ． | 栄養断片、タンパク質、および方法 |
| JP2016065038A (ja) * | 2014-08-18 | 2016-04-28 | 森永乳業株式会社 | プロリルオリゴペプチダーゼ阻害剤 |
| JP2017008104A (ja) * | 2014-06-16 | 2017-01-12 | キリン株式会社 | 記憶学習機能及び／又は認知機能を増強するための組成物 |
| JP2020509057A (ja) * | 2017-03-04 | 2020-03-26 | 国立大学法人京都大学 | 治療用ペプチド |
| WO2020167668A1 (en) * | 2019-02-11 | 2020-08-20 | Zumutor Biologics Inc. | Anti-clec2d antibodies and methods of use thereof |
| JP2020198791A (ja) * | 2019-06-06 | 2020-12-17 | 雪印メグミルク株式会社 | 睡眠改善用組成物及び組成物を含む食品、医薬品、飼料 |
-
2022
- 2022-03-24 JP JP2023509295A patent/JPWO2022202985A1/ja active Pending
- 2022-03-24 WO PCT/JP2022/013912 patent/WO2022202985A1/ja not_active Ceased
- 2022-03-24 US US18/281,350 patent/US20240158440A1/en active Pending
- 2022-03-24 CN CN202280019836.9A patent/CN116997561A/zh active Pending
- 2022-03-24 EP EP22775766.3A patent/EP4317173A4/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001136995A (ja) * | 1999-11-11 | 2001-05-22 | Calpis Co Ltd | トリペプチドの製造方法 |
| US20120077751A1 (en) * | 2003-10-08 | 2012-03-29 | Yu Tian Wang | Methods for modulating neuronal responses |
| JP2012031139A (ja) * | 2009-12-28 | 2012-02-16 | Calpis Co Ltd | 脳機能改善作用を有するペプチド |
| JP2015519878A (ja) * | 2012-03-26 | 2015-07-16 | プロニュートリア・インコーポレイテッドＰｒｏｎｕｔｒｉａ， Ｉｎｃ． | 栄養断片、タンパク質、および方法 |
| JP2017008104A (ja) * | 2014-06-16 | 2017-01-12 | キリン株式会社 | 記憶学習機能及び／又は認知機能を増強するための組成物 |
| JP2016065038A (ja) * | 2014-08-18 | 2016-04-28 | 森永乳業株式会社 | プロリルオリゴペプチダーゼ阻害剤 |
| JP2020509057A (ja) * | 2017-03-04 | 2020-03-26 | 国立大学法人京都大学 | 治療用ペプチド |
| WO2020167668A1 (en) * | 2019-02-11 | 2020-08-20 | Zumutor Biologics Inc. | Anti-clec2d antibodies and methods of use thereof |
| JP2020198791A (ja) * | 2019-06-06 | 2020-12-17 | 雪印メグミルク株式会社 | 睡眠改善用組成物及び組成物を含む食品、医薬品、飼料 |
Non-Patent Citations (3)
| Title |
|---|
| FREEMAN D. ET AL.: "Sleep disturbance and psychiatricdisorders", LANCET PSYCHIATRY, vol. 7, JPN6026005755, 2020, pages 628 - 637, ISSN: 0005796919 * |
| HALBREICH U. ET AL.: "Stress-related physical and mental disorders:a new paradigm", BJPSYCH ADVANCES, vol. 27, JPN6026005756, May 2021 (2021-05-01), pages 145 - 152, ISSN: 0005796918 * |
| XIPING Z. ET AL.: "The enhanced serotonin (5-HT) synthesis and anti-oxidative roles ofTrp oligopeptide in combating anx", JOURNAL OF FUNCTIONAL FOODS, vol. 67, JPN6026005754, 25 February 2020 (2020-02-25), pages 1 - 11, ISSN: 0005796920 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20240158440A1 (en) | 2024-05-16 |
| WO2022202985A1 (ja) | 2022-09-29 |
| CN116997561A (zh) | 2023-11-03 |
| EP4317173A4 (en) | 2025-03-19 |
| EP4317173A1 (en) | 2024-02-07 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20231219 |
|
| RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20240112 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20240112 Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240112 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250324 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260217 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260416 |